SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021910
Filing Date
2020-05-06
Accepted
2020-05-06 16:03:56
Documents
77
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-10q_20200331.htm 10-Q 2132597
2 EX-31.1 mnkd-ex311_7.htm EX-31.1 9091
3 EX-31.2 mnkd-ex312_6.htm EX-31.2 9069
4 EX-32.1 mnkd-ex321_8.htm EX-32.1 7366
5 EX-32.2 mnkd-ex322_9.htm EX-32.2 7327
  Complete submission text file 0001564590-20-021910.txt   9153153

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnkd-20200331.xml EX-101.INS 2056984
7 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20200331.xsd EX-101.SCH 77569
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20200331_cal.xml EX-101.CAL 63543
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20200331_def.xml EX-101.DEF 308516
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20200331_lab.xml EX-101.LAB 548779
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20200331_pre.xml EX-101.PRE 451783
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 20852560
SIC: 2834 Pharmaceutical Preparations